News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
312,625 Results
Type
Article (69122)
Company Profile (456)
Press Release (243029)
Multimedia
Podcasts (132)
Webinars (23)
Section
Business (78901)
Career Advice (865)
Deals (13387)
Drug Delivery (109)
Drug Development (33432)
Employer Resources (68)
FDA (6006)
Job Trends (6252)
News (122964)
Policy (12277)
Tag
2027 BioCapital Elite (1)
2027 BioMidwest Elite (2)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (2)
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (2)
2027 Biotech Beach Standard (2)
2027 Genetown Elite (4)
2027 Genetown Standard (7)
2027 Pharm Country Elite (2)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (7)
Academia (822)
Academic (2)
Accelerated approval (40)
ADA (47)
Adcomms (21)
Allergies (134)
Alliances (11347)
ALS (182)
Alzheimer's disease (1035)
Antibody-drug conjugate (ADC) (466)
Approvals (6504)
Artificial intelligence (625)
ASCO (229)
Autoimmune disease (290)
Automation (54)
Bankruptcy (144)
Best Places to Work (4908)
BIO (31)
BIOSECURE Act (14)
Biosimilars (196)
Biotechnology (314)
Bladder cancer (195)
Brain cancer (57)
Breast cancer (667)
Cancer (5274)
Cardiovascular disease (451)
Career advice (754)
Career pathing (25)
CAR-T (294)
CDC (33)
Celiac Disease (1)
Cell therapy (787)
Cervical cancer (42)
Clinical research (32948)
Collaboration (1720)
Commercialization (3)
Company closure (5)
Compensation (1118)
Complete response letters (60)
COVID-19 (1137)
CRISPR (98)
C-suite (919)
Cystic fibrosis (99)
Data (7125)
Decentralized trials (1)
Denatured (49)
Depression (149)
Dermatology (83)
Diabetes (541)
Diagnostics (2960)
Digital health (48)
Diversity (13)
Diversity, equity & inclusion (16)
Drug discovery (323)
Drug pricing (154)
Drug shortages (17)
Duchenne muscular dystrophy (228)
Earnings (52929)
Editorial (52)
Employer branding (12)
Employer resources (61)
Events (40994)
Executive appointments (869)
FDA (9260)
Fibrodysplasia Ossificans Progressiva (9)
Friedreich's ataxia (17)
Frontotemporal dementia (26)
Funding (1466)
Gene editing (200)
Generative AI (57)
Gene therapy (577)
GLP-1 (1095)
Government (1808)
Grass and pollen (6)
Guidances (403)
Healthcare (7106)
Hematology (198)
HIV (84)
Huntington's disease (50)
Idiopathic pulmonary fibrosis (1)
IgA nephropathy (96)
Immunology and inflammation (261)
Immuno-oncology (84)
Indications (184)
Infectious disease (1418)
Inflammatory bowel disease (150)
Inflation Reduction Act (11)
Influenza (106)
Intellectual property (215)
Interviews (139)
IPO (7702)
IRA (35)
Job creations (1683)
Job search strategy (652)
JPM (26)
Kidney cancer (23)
Labor market (84)
Layoffs (349)
Leadership (26)
Legal (2594)
Licensing (1)
Liver cancer (71)
Longevity (17)
Lung cancer (726)
Lymphoma (439)
Machine learning (43)
Management (21)
Manufacturing (833)
Marketing (9)
MASH (186)
Medical affairs (1)
Medical device (5176)
Medtech (5325)
Mergers & acquisitions (6707)
Metabolic disorders (1419)
mRNA (115)
Multiple sclerosis (172)
NASH (18)
Neurodegenerative disease (382)
Neuropsychiatric disorders (93)
Neuroscience (2345)
Neurotech (1)
NextGen: Class of 2026 (2268)
Non-profit (1524)
Now hiring (58)
Obesity (661)
Opinion (166)
Ovarian cancer (200)
Pain (194)
Pancreatic cancer (268)
Parkinson's disease (295)
Partnered (19)
Patents (428)
Patient recruitment (600)
Peanut (39)
People (11713)
Pharmaceutical (79)
Pharmacy benefit managers (26)
Phase 1 (8890)
Phase 2 (13852)
Phase 3 (12237)
Pipeline (8480)
Policy (218)
Postmarket research (1829)
Preclinical (3738)
Press Release (72)
Prostate cancer (285)
Psychedelics (54)
Radiopharmaceuticals (201)
Rare diseases (932)
Real estate (1772)
Recruiting (30)
Regulatory (12127)
Reports (42)
Research institute (763)
Resumes & cover letters (121)
Rett syndrome (45)
RNA editing (17)
RSV (78)
Schizophrenia (144)
Series A (248)
Series B (178)
Service/supplier (15)
Sickle cell disease (100)
Special edition (22)
Spinal muscular atrophy (161)
Sponsored (37)
Startups (1054)
State (1)
Stomach cancer (12)
Supply chain (104)
Tariffs (58)
The Weekly (82)
Vaccines (754)
Venture capital (100)
Weight loss (465)
Women's health (107)
Worklife (15)
Date
Today (99)
Last 7 days (360)
Last 30 days (1515)
Last 365 days (23402)
2026 (13658)
2025 (24495)
2024 (20582)
2023 (15332)
2022 (20012)
2021 (21150)
2020 (18684)
2019 (15477)
2018 (11867)
2017 (13021)
2016 (12976)
2015 (14412)
2014 (11614)
2013 (10925)
2012 (11513)
2011 (11647)
2010 (10508)
Location
Africa (685)
Alabama (51)
Alaska (6)
Arizona (232)
Arkansas (13)
Asia (19661)
Australia (3858)
California (11078)
Canada (2750)
China (1214)
Colorado (469)
Connecticut (486)
Delaware (394)
Europe (50604)
Florida (1503)
Georgia (345)
Hawaii (5)
Idaho (37)
Illinois (1005)
India (82)
Indiana (529)
Iowa (18)
Japan (535)
Kansas (88)
Kentucky (46)
Louisiana (55)
Maine (52)
Maryland (1159)
Massachusetts (8034)
Michigan (300)
Minnesota (520)
Mississippi (4)
Missouri (120)
Montana (27)
Nebraska (17)
Nevada (124)
New Hampshire (68)
New Jersey (3004)
New Mexico (30)
New York (2833)
North Carolina (1316)
North Dakota (11)
Northern California (5513)
Ohio (354)
Oklahoma (15)
Oregon (27)
Pennsylvania (1984)
Puerto Rico (20)
Rhode Island (34)
South America (723)
South Carolina (50)
South Dakota (1)
Southern California (4394)
Tennessee (186)
Texas (1716)
United States (38354)
Utah (292)
Vermont (2)
Virginia (272)
Washington D.C. (51)
Washington State (802)
West Virginia (4)
Wisconsin (142)
Wyoming (1)
312,625 Results for "7".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Job Trends
7 companies hiring in Boston
Looking for a job in Boston? Here’s a list of 7 companies on
BioSpace
currently hiring biopharma roles in Boston–plus a few more hiring in Waltham and Weston.
June 18, 2026
·
1 min read
·
Chantal Dresner
Press Releases
L7 Informatics Advocates for Neuro-Symbolic AI in Regulated Life Sciences
L7 Informatics’ position is that generative AI has been deployed in regulated science with only half the architecture it needs, and that the missing half is an active knowledge graph generated at the point of execution.
July 23, 2026
·
1 min read
Job Trends
May layoffs hit nearly 7,000, with most cuts from Takeda, BioNTech
For the second time in 2026, the number of biopharma professionals affected by made or projected workforce reductions rose year over year. In May, layoffs spiked nearly 50%, mainly due to Takeda and BioNTech axing a combined 6,360 employees.
June 11, 2026
·
3 min read
·
Angela Gabriel
Press Releases
Inside the 98 Percent: L7 Informatics on the Operational Harness That Determines Pharma’s Agentic AI Outcomes
L7 Informatics CEO, Vasu Rangadass, Ph.D., examines the architectural principle separating pharmaceutical AI experimentation from enterprise-scale deployment.
June 12, 2026
·
1 min read
Job Trends
7 companies hiring in New York now
Looking for a biopharma job in New York? Check out the
BioSpace
list of seven companies hiring life sciences professionals like you.
July 29, 2026
·
1 min read
·
Angela Gabriel
Press Releases
L7 Informatics Makes the Case for an Agentic Operating System as the Strategic Foundation for Regulated Process Industries
L7 CEO Vasu Rangadass, Ph.D., argues that regulated process industries have reached the limits of point-solution modernization and must pivot to unified orchestration to unlock the promise of agentic AI.
June 15, 2026
·
1 min read
Press Releases
EssilorLuxottica: Q2/H1 2026 Results - Solid revenue trajectory at +9.7% in H1, with Q2 at +8.7%. Increasing profitability, with Adj. Operating Profit +15%.
July 28, 2026
·
2 min read
Press Releases
MustGrow Closes $3.7 Million Non-Brokered LIFE Offering
June 19, 2026
·
6 min read
FDA
7 FDA decisions to watch for in Q3
Many of the FDA’s decisions this quarter involve applications that have previously been delayed, declined or outright rejected, including one for an mRNA vaccine that became the center of controversy earlier this year.
July 2, 2026
·
7 min read
·
Tristan Manalac
Press Releases
L7 Informatics Challenges the Notion of the “AI Governance Layer” in Pharma
July 22, 2026
·
1 min read
1 of 31,263
Next
